MIR
vs
S
S&P TSX Composite Index (Canada)
MIR
Over the past 12 months, MIR has underperformed S&P TSX Composite Index (Canada), delivering a return of -42% compared to the S&P TSX Composite Index (Canada)'s +37% growth.
Stocks Performance
MIR vs S&P TSX Composite Index (Canada)
Performance Gap
MIR vs S&P TSX Composite Index (Canada)
Performance By Year
MIR vs S&P TSX Composite Index (Canada)
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
MedMira Inc
Glance View
MedMira, Inc. is a biotechnology company, which through its subsidiaries, engages in the research, development, manufacture, and commercialization of diagnostics and technology platforms. The company is headquartered in Halifax, Nova Scotia. The firm is engaged in the development and commercialization of rapid diagnostics and technology platforms. The MedMira Rapid Vertical Flow (RVF) Technology platform is the basis for the Company's line of rapid tests. Its technology platform detects multiple biomarkers specific to several diseases using a single cartridge. Its Multiplo line of rapid tests for human immunodeficiency virus (HIV), Hepatitis B and C, and syphilis uses the platforms capabilities to deliver approximately up to four test results using one test cartridge and one drop of specimen. The company also has a research product line that facilitates technology licensing, contract manufacturing, and regulatory consulting. The firm sells its rapid tests through a network of medical distributors and strategic business development partners to customers in all sectors of the healthcare industry, including laboratories, hospitals and point-of-care clinics, among others.
